FDA Must Strive for Progress, Not Perfection

more+
less-

When it comes to research on promising new classes of pain therapies, the agency must weigh its understandable caution regarding safety concerns against unmet needs of millions of patients suffering with pain.

LOADING PDF: If there are any problems, click here to download the file.

Published In: Health Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Michael Barnes, DCBA Law & Policy | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »